Date of Report (Date of earliest event reported): June 17, 2026
SABRA HEALTH CARE REIT, INC.
(Exact name of registrant as specified in its charter)
Maryland
001-34950
27-2560479
(State of Incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
1781 Flight Way
Tustin
CA
92782
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number including area code: (888) 393-8248
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common stock, $0.01 par value
SBRA
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Item 5.07
Submission of Matters to a Vote of Security Holders.
(a)The annual meeting of stockholders of the Company (the “Annual Meeting”) was held on June 17, 2026.
(b)At the Annual Meeting, the Company’s stockholders (i) elected the seven nominees identified in the table below to the Board of Directors of the Company to serve until the Company’s 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified (“Election of Directors”), (ii) ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 (“Auditor Ratification”) and (iii) approved, on an advisory basis, the compensation of the Company’s named executive officers as set forth in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 24, 2026 (“Advisory Compensation Vote”). Set forth below are the final voting tallies for the Annual Meeting:
Election of Directors
For
Against
Abstain
Broker Non-Votes
Craig A. Barbarosh
203,295,021
4,352,019
144,422
20,607,679
Katie Cusack
205,669,611
1,508,172
613,679
20,607,679
Michael J. Foster
201,703,451
5,940,779
147,232
20,607,679
Lynne S. Katzmann
202,722,219
4,938,575
130,668
20,607,679
Ann Kono
205,652,052
1,521,149
618,261
20,607,679
Jeffrey A. Malehorn
206,395,107
1,254,574
141,781
20,607,679
Richard K. Matros
201,695,777
5,948,753
146,932
20,607,679
Auditor Ratification
For
Against
Abstain
Broker Non-Votes
226,576,585
1,648,639
173,917
—
Advisory Compensation Vote
For
Against
Abstain
Broker Non-Votes
199,568,777
7,867,562
355,123
20,607,679
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SABRA HEALTH CARE REIT, INC.
Date: June 17, 2026
/S/ MICHAEL COSTA
Name:
Michael Costa
Title:
Chief Financial Officer, Treasurer and Executive Vice President